[go: up one dir, main page]

DK0670904T3 - Vektor til ekspression af terapeutisk relevante gener - Google Patents

Vektor til ekspression af terapeutisk relevante gener

Info

Publication number
DK0670904T3
DK0670904T3 DK94900042T DK94900042T DK0670904T3 DK 0670904 T3 DK0670904 T3 DK 0670904T3 DK 94900042 T DK94900042 T DK 94900042T DK 94900042 T DK94900042 T DK 94900042T DK 0670904 T3 DK0670904 T3 DK 0670904T3
Authority
DK
Denmark
Prior art keywords
vector
expression
therapeutically relevant
relevant genes
gene
Prior art date
Application number
DK94900042T
Other languages
Danish (da)
English (en)
Inventor
Ulrike Stein
Wolfgang Walther
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Application granted granted Critical
Publication of DK0670904T3 publication Critical patent/DK0670904T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK94900042T 1992-11-12 1993-11-10 Vektor til ekspression af terapeutisk relevante gener DK0670904T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4238778A DE4238778C2 (de) 1992-11-12 1992-11-12 Vektor zur Expression von therapeutisch relevanten Genen
PCT/DE1993/001086 WO1994011522A2 (fr) 1992-11-12 1993-11-10 Vecteur d'expression de genes utiles en therapie

Publications (1)

Publication Number Publication Date
DK0670904T3 true DK0670904T3 (da) 2003-07-14

Family

ID=6473100

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900042T DK0670904T3 (da) 1992-11-12 1993-11-10 Vektor til ekspression af terapeutisk relevante gener

Country Status (6)

Country Link
EP (1) EP0670904B1 (fr)
JP (1) JPH09504161A (fr)
AT (1) ATE234929T1 (fr)
DE (2) DE4238778C2 (fr)
DK (1) DK0670904T3 (fr)
WO (1) WO1994011522A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK50699A3 (en) * 1996-10-18 2000-05-16 Canji Inc Methods and compositions for delivery and expression of interferon-'alpha' nucleic acids
DE19860602A1 (de) * 1998-12-29 2000-07-06 Max Delbrueck Centrum Gentransfervektor für die Diagnostik und die Therapie von malignen Tumoren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339654C (fr) * 1988-06-03 1998-02-03 Ursula A. Germann Therapie genitique utilisant la fusion de genes pour les troubles hereditaires or acquis

Also Published As

Publication number Publication date
EP0670904A1 (fr) 1995-09-13
EP0670904B1 (fr) 2003-03-19
WO1994011522A3 (fr) 1994-09-29
DE4238778C2 (de) 1995-11-02
JPH09504161A (ja) 1997-04-28
DE59310334D1 (de) 2003-04-24
DE4238778A1 (de) 1994-05-19
ATE234929T1 (de) 2003-04-15
WO1994011522A2 (fr) 1994-05-26

Similar Documents

Publication Publication Date Title
FI951404A0 (fi) Adenovirusvektoreita vieraiden geenien siirtämiseksi keskushermostojärjestelmän, erityisesti aivojen, soluihin
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
DE69114299D1 (de) Verfahren und zusammensetzungen für gentherapie und stärkung des immunsystems.
SE8004066L (sv) Plasmider, deras framstellning, deras anvendning som vektorer, dervid erhallna celler samt dessas anvendning
NO981353L (no) Regulerte gener og anvendelser derav
AU1955388A (en) Method for potentiating and inhibiting insulin-like growth factor activity
DK0719343T3 (da) Adeno-associerede virale (AAV) liposomer og fremgangsmåde forbundet dermed
DK0939763T3 (da) Styret skift-medieret DNA-rekombination
FI855141A7 (fi) Rekombinantti-DNA-vektoreita, jotka kykenevät ilmaisemaan apoaequoriinia.
DE69830663D1 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
NO990086L (no) Avkortete, l°selige tumornekrosefaktorreseptorer av type I og type II
DK1222298T3 (da) Vektorer og fremgangsmåder til rekombinant proteinekspression
DK0832258T3 (da) Opstrøms aktivatorsekvenser og rekombinante promotorsekvenser, der er funktionelle i Yarrowia og vektorer indeholdende disse
WO1997022695A3 (fr) Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer
FI961666A7 (fi) Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria
FI961202A0 (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
DE69838681D1 (de) Escherichia coli hochexpressionsvektor
DE69830910D1 (de) Kaliumkanal-proteine zur verwendung in gentherapie zur verminderung von erektiler dysfunktion
DK0670904T3 (da) Vektor til ekspression af terapeutisk relevante gener
DK0817858T3 (da) Vektorer, som indeholder terapeutiske gener for antimikrobielle peptider, til anvendelse ved genterapi
ES2113948T3 (es) Promotor de levadura y su utilizacion.
ES8800985A1 (es) Procedimiento de preparar proteinas.
DE59913022D1 (de) Selbstdeletierende vektoren für die krebstherapie
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
DE59510829D1 (de) Gentherapeutisches verfahren unter verwendung von dna-vektoren ohne selektionsmarker-gen